Trinseo (TSE) Q3 2024 earnings summary

Executive summary

• Q3 2024 net loss was $87 million, including $26 million in pre-tax restructuring charges, with EPS of negative $2.47; Adjusted EBITDA rose to $66 million, up $25 million year-over-year, driven by restructuring, improved product mix, and lower input costs, though Americas Styrenics underperformed due to outages.

• Free cash flow improved sequentially but remained negative $3 million in Q3, with cash provided by operations at $9 million; ending cash was $167 million and total liquidity $340.3 million.

• Announced further restructuring, including business segment consolidation, workforce reductions, and exit from virgin polycarbonate production at Stade, Germany, targeting $25 million in cost savings for 2025 and $30 million by 2026.

• Americas Styrenics joint sale process is ongoing, with a transaction expected in the first half of 2025.

• Sales of recycled-content products increased 57% year-to-date, now representing a growing share of company margin.

Financial highlights

• Q3 2024 net sales were $868 million, down 1% year-over-year, with an 8% volume decline mainly from portfolio optimization in polystyrene and weak demand in Asia and Europe, partially offset by a 7% price increase.

• Gross profit increased to $80.6 million from $31.3 million year-over-year, and Adjusted EBITDA margin improved to 8%.

• Interest expense rose to $72.3 million in Q3, up from $46.6 million year-over-year, mainly due to higher rates and PIK interest elections.

• Free cash flow for Q3 was negative $3 million, with a $14–16 million decrease in trade working capital.

• Net debt at quarter-end was $2.44 billion.

Outlook and guidance

• Q4 2024 Adjusted EBITDA is expected between $40 million and $50 million, with a net loss forecasted between $81 million and $71 million; free cash flow is projected to turn positive due to seasonal working capital improvements.

• Full-year 2024 net loss is forecasted at $312 million to $302 million, with Adjusted EBITDA of $218 million to $228 million.

• 2025 restructuring costs are expected to be similar to 2024 at $45 million, with a material drop-off in 2026; 2025 Adjusted EBITDA is expected to exceed $300 million, driven by restructuring, business wins, and full-year AmSty benefits.

• Cash flow break-even for 2025 is projected in the low $300 million EBITDA range, with lower cash interest expected if rates decline.

• Modest demand improvement is anticipated in Q1 2025, especially in building and construction, supported by easing interest rates.